Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Pisa · university | Italy | none recorded | 0 | 878 | 11,217 | none recorded | - |
Shanghai · hospital | China | none recorded | 0 | 468 | 4,967 | - | |
Fukuoka · hospital | Japan | none recorded | 0 | 228 | 1,276 | - | |
Munich · consortium | Germany | none recorded | 0 | not matched | - | none recorded | - |
Kashiwa, Chiba · cancer center | Japan | none recorded | 0 | not matched | - | - | |
Cologne · consortium | Germany | none recorded | 0 | not matched | - | - | |
Olney, MD · consortium | United States | none recorded | 0 | not matched | - | none recorded | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Multiple endocrine neoplasia type 2 but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.